Notably, we found a positive correlation between NRF2 and ABCC1 gene expression in three cohorts of glioma patients (CGGA, TCGA, and REMBRANDT) (Figs. 6A and S2A, S3A). This evidence concerns the gene ABCC1 and central nervous system cancer.